Pharmanutra S.p.A. (BIT: PHN)
Italy
· Delayed Price · Currency is EUR 54.20
+0.20 (0.37%)
Dec 27, 2024, 5:35 PM CET
Pharmanutra Revenue
Pharmanutra had revenue of 27.44M EUR in the quarter ending September 30, 2024, with 25.18% growth. This brings the company's revenue in the last twelve months to 113.13M, up 19.63% year-over-year. In the year 2023, Pharmanutra had annual revenue of 101.03M with 21.64% growth.
Revenue (ttm)
113.13M
Revenue Growth
+19.63%
P/S Ratio
4.64
Revenue / Employee
950.63K
Employees
105
Market Cap
522.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 101.03M | 17.97M | 21.64% |
| Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
| Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
| Dec 31, 2020 | 56.77M | 3.10M | 5.78% |
| Dec 31, 2019 | 53.67M | 6.87M | 14.67% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.27B |
| Amplifon | 2.36B |
| DiaSorin | 1.18B |
| EL.En. | 665.50M |
| Philogen | 3.92M |
| Safilo Group | 1.01B |
| GPI S.p.A. | 484.01M |
| EuKedos | 50.70M |